Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RGD Hydrogel with MINST for Periodontal Intrabony Defects
NCT06936605Not yet recruiting
- Sponsor
- Minia University
- Start
- Apr 2025
- Primary completion
- Sep 2025
- Modality
- Peptides
01
Overview
Randomised, double-blind trial of arginylglycylaspartic acid in periodontitis (3 arms), sponsored by Minia University. Primary endpoint: Clinical Attachment Level at 6 months. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
arginylglycylaspartic acid
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT06936605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06936605.